LifeVantage
Corporation (OTCBB: LFVN),the maker ofProtandim®,
the only product clinically proven to slow the progressive rate of
aging, today announced that David Brown, LifeVantage President and CEO,
has been invited to present at the upcoming ROTH Capital Conference to
be held February 16-18, 2009 at the Ritz Carlton, Laguna Niguel in Dana
Point, California. Brown is scheduled to speak on Monday, February 16 at
12:40 p.m. PT. The presentation will be available via webcast on www.lifevantage.com/2/investor.
Late in 2008, LifeVantage was featured in The EdgeWater Micro Monthly in
which the editor David Lavigne wrote, "They have in a few months
restructured a number of things (distribution- both domestic and
international, etc.), embarked on adding some new product lines, skin
care for example, which I think has enormous potential, and have begun
to lay the ground work for entrees into other verticals, veterinary
might be an example."
"LifeVantage is pleased to be invited to present at the well respected
ROTH Conference," said David Brown, LifeVantage President and CEO. "Now
is the ideal time to share the LifeVantage story with members of the
financial community who are active in the Small/Micro Cap markets. We
have recently increased sales distribution, as well as expanded online
presence, which has proved highly successful in broadening our overall
brand awareness. Our branding efforts, coupled with the many scientific
studies underway nationwide at leading universities and research
institutes to study the effect of Protandim on various diseases and
health conditions, and the fact that the "health and wellness" trend
continues to grow and become a daily part of consumers' lifestyle is
generating greater interest in the Company."
About Roth Capital Partners, LLC
With corporate headquarters in Newport Beach, California and offices in
strategic locations in the Western United States and Shanghai, China,
Roth Capital Partners, LLC is a full service investment bank serving
corporate and institutional clients throughout the world. Offering a
wide array of investment banking services including: initial public
offerings, follow-ons, PIPEs, private placements, mergers and
acquisitions, investment research, and institutional sales and trading,
the firm is perhaps best known for finding, funding and fostering the
growth of emerging companies. It is a member of the Financial Industry
Regulatory Authority ("FINRA"), and the Securities Investor Protection
Corporation (SIPC). Visit the Roth Capital Partners website at www.roth.com.
About
Protandim®
Protandim® is a groundbreaking, clinically proven solution
for healthy aging. This patented anti-oxidant therapy is 1000's of times
more powerful than red wine, oranges, blueberries, acai juice or other
popular anti-oxidant supplements. Protandim works by increasing the
body's natural anti-oxidant protection at the cellular level, triggering
cells to produce naturally occurring protective antioxidant enzymes such
as super oxide dismutase (SOD), catalase, and glutathione.
A peer-reviewed scientific study shows that after 30 days of taking
Protandim, free radicals decreased an average of 40 percent, slowing the
progressive aging factors to the level of a 20 year old. Protandim is
currently the subject of over 20 scientific studies at leading
universities and research institutes. For more information, please visitwww.LifeVantage.comor contact Jan Strode at (619) 890-4040.
About
LifeVantage Corporation
LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science
based, natural products company, dedicated to helping people reach their
health and wellness goals through science-based solutions to oxidative
stress. Founded in 2003 and based in Colorado, LifeVantage develops
nutraceutical products, including Protandim,
that leverage the company's expertise and that are intended to deliver
significant health benefits to consumers. For more information, visit www.lifevantage.com
or contact Jan Strode at (619) 890-4040.
This document contains forward-looking statements made pursuant to
the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995.The Company uses the words "anticipate," "believe,"
"could," "should," "estimate," "expect," "intend," "may," "predict,"
"project," "plan," "target" and similar terms and phrases, including
references to assumptions, to identify forward-looking statements.These
forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the Company
and involve known and unknown risks and uncertainties that may cause the
Company's actual results or outcomes to be materially different from
those anticipated and discussed herein.These risks and
uncertainties include, among others, the risk that government regulators
and regulations could adversely affect our business; future laws or
regulations may hinder or prohibit the production or sale of our
existing product and any future products; unfavorable publicity could
materially hurt our business; and the Company's ability to protect our
intellectual property rights and the value of our product.These
and other risk factors are discussed in greater detail in the Company's
Annual Report on Form 10-KSB under the caption "Risk Factors", and in
other documents filed the Company from time to time with the Securities
and Exchange Commission.The Company cautions investors not to
place undue reliance on the forward-looking statements contained in this
document.All forward-looking statements are based on information
currently available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of this
document, except as required by law.
*These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.
Note to Editors: Contact Jan Strode at 619-890-4040 for interviews,
photography, and other requests.
For LifeVantage Corporation
Jan Strode, 619-890-4040
Jean
Golden, 612-385-2324